Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK

Emergency Medicine Journal

Volumn 28, Issue 9, 2011, Pages 764-765

  Wood, David Michael ^a   Stribley, Vasoulla ^b   Dargan, Paul Ivor ^a   Davies, Susannah ^c   Holt, David W ^c   Ramsey, John ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ARTICLE; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG LEGISLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; TABLET; UNITED KINGDOM;

GREAT BRITAIN; HALLUCINOGENS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; STREET DRUGS; TABLETS;

EID: 80052113224     PISSN: 14720205     EISSN: 14720213     Source Type: Journal    
DOI: 10.1136/emj.2010.092270     Document Type: Article

References (9)

1. Firma E. Merck in Darmstadt (1914-05-16). German Patent 274350: Verfahren zur Darstellung von Alkyloxyaryl-, Dialkyloxyaryl- und Alkylendioxyarylaminopropanen bzw. deren am Stickstoff monoalkylierten Derivaten. Kaiserliches Patentamt. http://v3.espacenet.com/publicationDetails/ originalDocument?CC=DE&NR=274350C&FT=D. (accessed 27 July 2010).
2. Hardman HF, Haavik CO, Seevers MH. Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals. Toxicol Appl Pharmacol 1973;25:299-309.
3. Hall AP, Henry JA. Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: Overview of pathophysiology and clinical management. Br J Anaesth 2006;96:678-85. (Pubitemid 43786681)
4. Greene SL, Dargan PI, O'Connor N, et al. Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy"). Am J Emerg Med 2003;21:121-4. (Pubitemid 36396822)
5. Teng SF, Wu SC, Liu C, et al. Characteristics and trends of 3,4-methylenedioxymethamphetamine (MDMA) tablets found in Taiwan from 2002 to February 2005. Forensic Sci Int 2006;161:202-8. (Pubitemid 44142909)
6. Mc Fadden K, Gillespie J, Carney B, et al. Development and application of a high-performance liquid chromatography method using monolithic columns for the analysis of ecstasy tablets. J Chromatogr A 2006;1120:54-60. (Pubitemid 43866763)
7. Ramsey JD, Butcher MA, Murphy MF, et al. A new method to monitor drugs at dance venues. BMJ 2001;323:603. (Pubitemid 32846128)
8. Moffat AC, ed. Clarke's isolation and identification of drugs. 2nd edn. London: Pharmaceutical Press, 1986:139.
9. Kenyon SL, Ramsey JD, Lee T, et al. Analysis for identification in amnesty bin samples from dance venues. Ther Drug Monit 2005;27:793-8. (Pubitemid 44391737)